Serveur d'exploration sur la Covid et les espaces publics

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.

Identifieur interne : 000133 ( Main/Exploration ); précédent : 000132; suivant : 000134

Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.

Auteurs : Fatima N. Mirza [États-Unis] ; Amyn A. Malik [États-Unis] ; Chandra Couzens [États-Unis] ; Saad B. Omer [États-Unis]

Source :

RBID : pubmed:32888977

Descripteurs français

English descriptors

Abstract

Although direct detection of SARS-CoV2 in symptomatic or asymptomatic individuals is the ideal epidemiological tool for determining the burden of disease, the lack of availability of testing can preclude its wider implementation as a robust surveillance system. We correlated the use of the derivative influenza-negative influenza-like illness (fnILI) z-score from the US Centers for Disease Control and Prevention as a proxy for incident cases and disease-specific deaths. For every unit increase of fnILI z-score, the number of cases increased by 376.5 (95% CI [202.5, 550.5]) and number of deaths increased by 10.2 (95% CI [5.4, 15.0]). FnILI data may serve as an accurate outcome measurement to track the spread of COVID-19 infection and disease, and allow for informed and timely decision-making on public health interventions.

DOI: 10.1016/j.jinf.2020.08.046
PubMed: 32888977
PubMed Central: PMC7462572


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.</title>
<author>
<name sortKey="Mirza, Fatima N" sort="Mirza, Fatima N" uniqKey="Mirza F" first="Fatima N" last="Mirza">Fatima N. Mirza</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Yale School of Medicine, Yale University, New Haven, CT 06510, United States. Electronic address: fatima.mirza@yale.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Yale School of Medicine, Yale University, New Haven, CT 06510</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Malik, Amyn A" sort="Malik, Amyn A" uniqKey="Malik A" first="Amyn A" last="Malik">Amyn A. Malik</name>
<affiliation wicri:level="1">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510</wicri:regionArea>
<wicri:noRegion>06510</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Couzens, Chandra" sort="Couzens, Chandra" uniqKey="Couzens C" first="Chandra" last="Couzens">Chandra Couzens</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Omer, Saad B" sort="Omer, Saad B" uniqKey="Omer S" first="Saad B" last="Omer">Saad B. Omer</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT 06510, United States; Yale School of Nursing, Yale University, Orange, CT 06477, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT 06510, United States; Yale School of Nursing, Yale University, Orange, CT 06477</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32888977</idno>
<idno type="pmid">32888977</idno>
<idno type="doi">10.1016/j.jinf.2020.08.046</idno>
<idno type="pmc">PMC7462572</idno>
<idno type="wicri:Area/Main/Corpus">000126</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000126</idno>
<idno type="wicri:Area/Main/Curation">000126</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000126</idno>
<idno type="wicri:Area/Main/Exploration">000126</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.</title>
<author>
<name sortKey="Mirza, Fatima N" sort="Mirza, Fatima N" uniqKey="Mirza F" first="Fatima N" last="Mirza">Fatima N. Mirza</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Yale School of Medicine, Yale University, New Haven, CT 06510, United States. Electronic address: fatima.mirza@yale.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Yale School of Medicine, Yale University, New Haven, CT 06510</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Malik, Amyn A" sort="Malik, Amyn A" uniqKey="Malik A" first="Amyn A" last="Malik">Amyn A. Malik</name>
<affiliation wicri:level="1">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510</wicri:regionArea>
<wicri:noRegion>06510</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Couzens, Chandra" sort="Couzens, Chandra" uniqKey="Couzens C" first="Chandra" last="Couzens">Chandra Couzens</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Omer, Saad B" sort="Omer, Saad B" uniqKey="Omer S" first="Saad B" last="Omer">Saad B. Omer</name>
<affiliation wicri:level="2">
<nlm:affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT 06510, United States; Yale School of Nursing, Yale University, Orange, CT 06477, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT 06510, United States; Yale School of Nursing, Yale University, Orange, CT 06477</wicri:regionArea>
<placeName>
<region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of infection</title>
<idno type="eISSN">1532-2742</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Centers for Disease Control and Prevention, U.S. (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (virology)</term>
<term>Databases, Factual (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (virology)</term>
<term>Orthomyxoviridae (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (virology)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Bases de données factuelles (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Orthomyxoviridae (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Saisons (MeSH)</term>
<term>États-Unis (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Centers for Disease Control and Prevention, U.S.</term>
<term>Databases, Factual</term>
<term>Humans</term>
<term>Incidence</term>
<term>Orthomyxoviridae</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Bases de données factuelles</term>
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Incidence</term>
<term>Orthomyxoviridae</term>
<term>Pandémies</term>
<term>Saisons</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Although direct detection of SARS-CoV2 in symptomatic or asymptomatic individuals is the ideal epidemiological tool for determining the burden of disease, the lack of availability of testing can preclude its wider implementation as a robust surveillance system. We correlated the use of the derivative influenza-negative influenza-like illness (fnILI) z-score from the US Centers for Disease Control and Prevention as a proxy for incident cases and disease-specific deaths. For every unit increase of fnILI z-score, the number of cases increased by 376.5 (95% CI [202.5, 550.5]) and number of deaths increased by 10.2 (95% CI [5.4, 15.0]). FnILI data may serve as an accurate outcome measurement to track the spread of COVID-19 infection and disease, and allow for informed and timely decision-making on public health interventions.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32888977</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>11</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-2742</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>81</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2020</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of infection</Title>
<ISOAbbreviation>J Infect</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.</ArticleTitle>
<Pagination>
<MedlinePgn>793-796</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0163-4453(20)30581-8</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2020.08.046</ELocationID>
<Abstract>
<AbstractText>Although direct detection of SARS-CoV2 in symptomatic or asymptomatic individuals is the ideal epidemiological tool for determining the burden of disease, the lack of availability of testing can preclude its wider implementation as a robust surveillance system. We correlated the use of the derivative influenza-negative influenza-like illness (fnILI) z-score from the US Centers for Disease Control and Prevention as a proxy for incident cases and disease-specific deaths. For every unit increase of fnILI z-score, the number of cases increased by 376.5 (95% CI [202.5, 550.5]) and number of deaths increased by 10.2 (95% CI [5.4, 15.0]). FnILI data may serve as an accurate outcome measurement to track the spread of COVID-19 infection and disease, and allow for informed and timely decision-making on public health interventions.</AbstractText>
<CopyrightInformation>Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mirza</LastName>
<ForeName>Fatima N</ForeName>
<Initials>FN</Initials>
<AffiliationInfo>
<Affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Yale School of Medicine, Yale University, New Haven, CT 06510, United States. Electronic address: fatima.mirza@yale.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malik</LastName>
<ForeName>Amyn A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Couzens</LastName>
<ForeName>Chandra</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Omer</LastName>
<ForeName>Saad B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Yale Institute for Global Health, Yale University, 1 Church St, New Haven, CT 06510, United States; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT 06510, United States; Yale School of Nursing, Yale University, Orange, CT 06477, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>09</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Infect</MedlineTA>
<NlmUniqueID>7908424</NlmUniqueID>
<ISSNLinking>0163-4453</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002487" MajorTopicYN="N">Centers for Disease Control and Prevention, U.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CDC</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">ILI</Keyword>
<Keyword MajorTopicYN="N">Influenza</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>08</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>08</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>11</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>12</Hour>
<Minute>20</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32888977</ArticleId>
<ArticleId IdType="pii">S0163-4453(20)30581-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.jinf.2020.08.046</ArticleId>
<ArticleId IdType="pmc">PMC7462572</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Aging Med (Milton). 2020 May 22;3(2):102-109</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32661509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Apr;26(4):463-464</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32284619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microb Pathog. 2020 Oct;147:104390</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32681968</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Environ Res Public Health. 2020 Apr 14;17(8):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32295188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2020 Jun 29;148:e130</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32594937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pulmonology. 2020 Jun 6;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32540223</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Connecticut</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Connecticut">
<name sortKey="Mirza, Fatima N" sort="Mirza, Fatima N" uniqKey="Mirza F" first="Fatima N" last="Mirza">Fatima N. Mirza</name>
</region>
<name sortKey="Couzens, Chandra" sort="Couzens, Chandra" uniqKey="Couzens C" first="Chandra" last="Couzens">Chandra Couzens</name>
<name sortKey="Malik, Amyn A" sort="Malik, Amyn A" uniqKey="Malik A" first="Amyn A" last="Malik">Amyn A. Malik</name>
<name sortKey="Omer, Saad B" sort="Omer, Saad B" uniqKey="Omer S" first="Saad B" last="Omer">Saad B. Omer</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Wicri/explor/CovidPublicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000133 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000133 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Wicri
   |area=    CovidPublicV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32888977
   |texte=   Influenza-negative influenza-like illness (fnILI) Z-score as a proxy for incidence and mortality of COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32888977" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidPublicV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Dec 15 17:23:28 2020. Site generation: Wed Jan 27 15:07:40 2021